Table 1.
Growth medium | Presumptive microorganism | Growth conditions | Plating method | Reference | Organic wheatmeal | Mealworm larvae | Frass |
---|---|---|---|---|---|---|---|
log cfu g−1 | |||||||
PCA | Aerobic mesophilic bacteria | 30°C;48 h | Pour | (American Public Health Association, 1976) | 1.5 ± 0.08 c | 9.3 ± 0.04a | 7.8 ± 0.01b |
Spore forming bacteria | <1c | 2.3 ± 0.03 b | 4.1 ± 0.02a | ||||
MRS | Lactic acid bacteria | 30°C;48–72 h | Pour | (De Man et al., 1960) | 1.9 ± 0.08c | 8.3 ± 0.01a | 5.8 ± 0.01b |
MRS + ampicillin (8 mg L−1)* | Ampicillin resistant lactic acid bacteria | <1c | 2.2 ± 0.04a | 1.7 ± 0.05b | |||
MRS + vancomycin (8 mg L−1) * | Vancomycin resistant lactic acid bacteria | 1.3 ± 0.03 c | 7.1 ± 0.01a | 3.9 ± 0.01b | |||
ESA | Enterococci | 37°C;24–48 h | Spread | (Slanetz and Bartley, 1957) | 1.6 ± 0.07 c | 7.9 ± 0.01a | 6.7 ± 0.03b |
ESA + ampicillin (8 mg L−1) * | Ampicillin resistant enterococci | <1a | <1a | <1a | |||
ESA + gentamicin (128 mg L−1) * | HLAR enterococci | <1a | <1a | <1a | |||
ESA + vancomycin (4 mg L−1) * | Vancomycin resistant enterococci | <1c | 5.7 ± 0.03a | 2.6 ± 0.01b | |||
MSA | Staphylococci | 37°C;24–48 h | Spread | (Chapman, 1945; Bannerman, 2003) | <1b | 5.8 ± 0.01a | 5.4 ± 0.01a |
MSA + gentamicin (1 mg L−1) * | Gentamicin resistant staphylococci | <1b | 5.7 ± 0.01a | 5.3 ± 0.01a | |||
MSA + erythromycin (2 mg L−1) * | Erythromycin resistant staphylococci | <1c | 4.9 ± 0.04a | 2.8 ± 0.10b | |||
MSA + tetracycline (2 mg L−1)* | Tetracycline resistant staphylococci | <1c | 5.2 ± 0.01a | 4.6 ± 0.01b | |||
MSA + vancomycin (2 mg L−1) * | Vancomycin resistant coagulase positive staphylococci | <1b | 4.1 ± 0.04a | 4.3 ± 0.01a | |||
MSA + vancomycin (4 mg L−1) * | Vancomycin resistant coagulase negative staphylococci | <1c | 3.8 ± 0.01b | 4.3 ± 0.09a | |||
VRBGA | Enterobacteriaceae | 37°C;24 h | Pour | (American Public Health Association, 1976) | <1c | 7.5 ± 0.01a | 5.8 ± 0.01b |
VRBGA + ampicillin (8 mg L−1) * | Ampicillin resistant Enterobacteriaceae | <1c | 6.1 ± 0.01 a | 5.0 ± 0.01 b | |||
VRBGA + gentamicin (4 mg L−1) * | Gentamicin resistant Enterobacteriaceae | <1c | 2.5 ± 0.01a | 1.2 ± 0.20b | |||
PAB | Pseudomonadaceae | 30°C;24–48 h | Spread | (Geftic et al., 1979) | 1.0 ±0.00b | 6.7 ± 0.03a | 6.1 ± 0.02a |
PAB + gentamicin (4 mg L−1) * | Gentamicin resistant Pseudomonadaceae | <1c | 5.7 ± 0.03a | 3.2 ± 0.01b |
PCA, Plate Count Agar; MRS, de Man Rogosa Sharpe agar; ESA, Enterococcus Selective Agar, MSA, Mannitol Salt Agar; VRBGA, Violet Red Bile Glucose Agar; PAB, Pseudomonas Agar Base; HLAR, High-Level Aminoglycoside Resistance
the breakpoint values defined by European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2017)
Results of bacterial counts are expressed as mean values ± standard deviation of three independent experiments (one for each batch)
Means followed by different letters are significantly different (P < 0.05).